(PRESS RELEASE) MINNEAPOLIS — Walman Optical announced the addition of Avulux Migraine and Light Sensitivity Lenses to its portfolio, providing a groundbreaking solution for individuals suffering from migraine and light sensitivity. Avulux is the world’s only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks.
“We are thrilled to offer the Avulux lenses to our customers,” said Glen Funk, vice president, Walman Optical. “Our commitment is to provide innovative solutions that enrich the lives of patients through better vision. Avulux lenses are a game-changer for those affected by light sensitivity and migraine, and we believe this addition will make a significant impact.”
By partnering with an Avulux Authorized Labs, like Walman Optical, eye care professionals (ECPs) can enjoy a streamlined supply chain, exclusive bulk and wholesale discounts, and special incentives. Additionally, ECPs will receive comprehensive informational and promotional materials to seamlessly integrate Avulux lenses into their practice. Avulux and its Authorized Labs stand behind their lenses with warranties and guarantees, offering you and your patients’ peace of mind.
“We value Walman Optical’s partnership because, like us, they are committed to helping independent ECPs build practice growth and deliver an exceptional patient experience,” said Dr. Charles Posternack, president & CEO, Avulux. “Walman Optical believes in offering the latest in advanced technology combined with superior customer service and continuing education, and we welcome them to our growing roster of labs across the country.”
